Do I Need to Stay on Wegovy Forever?

You've reached your goal weight — and now you're wondering what happens next

It's one of the most common questions our prescribers at the nume clinical team field: you've done the hard work, the number on the scale has moved, and you're wondering whether you're now committed to weekly injections for the rest of your life. The honest clinical position is nuanced. Semaglutide doesn't fix the underlying biology that made weight management difficult; it manages it, in the same way a blood pressure medication manages hypertension without curing it. When you stop, the brain's appetite regulation returns to where it was before. The STEP 1 trial, published in the New England Journal of Medicine, followed participants for 68 weeks on semaglutide 2.4mg and found an average weight reduction of around 15%. A separate extension study found that the majority of that weight returned within a year of stopping, even for those who continued lifestyle changes. That's not a failure of willpower. It reflects how persistent the biological drivers of weight are. For many people, ongoing treatment is the clinically sound choice, and if you want to understand whether staying on Wegovy indefinitely is medically reasonable, that question has a more considered answer than most people expect. For others, a period of treatment followed by a supervised stop and close monitoring is entirely reasonable.

The pen you keep in the fridge door every Sunday becomes a long-term part of some people's routines. Whether it becomes part of yours is a medical question, not a commercial one.

What the NICE guidance actually says about how long you can use Wegovy

On the NHS, the picture has a formal boundary. NICE's appraisal of semaglutide (Wegovy), TA875, recommends it for a maximum of two years within a specialist weight management service with multidisciplinary support. If less than 5% weight loss is achieved after six months at the maintenance dose, NICE recommends reviewing whether to continue. These criteria govern NHS access specifically. Private treatment through a regulated pharmacy sits outside this two-year ceiling and is assessed by a prescriber on clinical merit each time a patient seeks a repeat. That said, the guidance exists because long-term evidence beyond two years was still maturing when TA875 was published. Prescribers working privately draw on the same clinical principles: does the benefit still outweigh the risk and cost for this individual person? If you're using Wegovy through a private route and want clarity on whether continuing makes sense for you, a structured conversation with your prescriber is the right starting point, not a general search.

A note on semaglutide more broadly: the active ingredient in Wegovy also appears in Ozempic, which is licensed for type 2 diabetes rather than weight loss. Those products are not interchangeable for our purposes here, and the evidence base above specifically concerns the weight-management dose.

Stopping, pausing or reducing: what actually happens and how to think about it

There's no clinical harm in stopping semaglutide abruptly. Unlike some medications, it doesn't require a taper protocol. But the consequences of stopping are real: hunger typically increases within a few weeks, and without intensive lifestyle support in place, weight tends to return gradually. The rate varies between people, but the STEP extension data gives a clear average trend. If you're thinking about stopping because of side effects, cost, a planned surgery or pregnancy, the conversation with your prescriber should happen before you stop rather than after. For those planning to conceive, NHS England's guidance on weight-management injections notes that these medicines are not recommended during pregnancy or when trying to conceive, and stopping with appropriate lead time is important. If cost is the driver, it's worth knowing what a full private treatment package typically covers before making a financial decision in isolation. And if you're in a planned pause rather than a permanent stop, your prescriber can advise on monitoring and what to watch for. There is also a related question that many people ask slightly differently: whether taking Wegovy forever is actually necessary, or whether some people do manage to stop without regain. The answer is that a minority do maintain weight loss after stopping, particularly those who have made substantial lifestyle changes, but they are genuinely in the minority, and predicting who they'll be in advance is not reliably possible.

Making a long-term plan that reflects your health, not just your weight

Duration of treatment is ultimately a health question. The conversations that go well are the ones where the prescriber knows the patient's weight history, any weight-related conditions like blood pressure or sleep apnoea, how the medicine has been tolerated, and what's changed in the person's life. Someone who has reversed a pre-diabetes diagnosis and built solid habits around eating and activity is in a different clinical position from someone who stopped losing weight and is experiencing persistent nausea at a low dose, and the considerations look different again for older patients, which is why we have specific guidance on using Wegovy safely as a senior. Both are legitimate situations; neither has a generic answer. If you're weighing up the long-term picture, our FAQs cover some of the practical questions patients ask most often, including whether you have to stay on Wegovy forever or whether there are realistic pathways off it. And if you'd like to talk through your specific situation with a prescriber rather than read general information, checking your eligibility for a consultation is where that starts. There's no obligation to continue, and no obligation to stop. That's the point: it's a clinical decision, made individually, reviewed every time you come back for a repeat. That's what proper medical oversight looks like.